Search Research

Found 616 bookmarks

Newest

20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999) - PubMed

20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999) - PubMed

20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999)

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999) - PubMed

19. Targeted nanoparticles for smarter cancer therapy: Original research article: Folate receptor targeted biodegradable polymeric doxorubicin micelles, 2004 - PubMed

19. Targeted nanoparticles for smarter cancer therapy: Original research article: Folate receptor targeted biodegradable polymeric doxorubicin micelles, 2004 - PubMed

19. Targeted nanoparticles for smarter cancer therapy: Original research article: Folate receptor targeted biodegradable polymeric doxorubicin micelles, 2004

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

19. Targeted nanoparticles for smarter cancer therapy: Original research article: Folate receptor targeted biodegradable polymeric doxorubicin micelles, 2004 - PubMed

18. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs: reflections and commentary a decade later: Original research article: Biodegradable block copolymers for delivery and proteins water-insoluble drugs, 2001 - PubMed

18. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs: reflections and commentary a decade later: Original research article: Biodegradable block copolymers for delivery and proteins water-insoluble drugs, 2001 - PubMed

18. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs: reflections and commentary a decade later: Original research article: Biodegradable block copolymers for delivery and proteins water-insoluble drugs, 2001

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

18. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs: reflections and commentary a decade later: Original research article: Biodegradable block copolymers for delivery and proteins water-insoluble drugs, 2001 - PubMed

17. Histidine based pH-responsive polymeric micelle for tumor: Original research article: Polymeric micelle for tumor pH folate-mediated targeting, 2003 - PubMed

17. Histidine based pH-responsive polymeric micelle for tumor: Original research article: Polymeric micelle for tumor pH folate-mediated targeting, 2003 - PubMed

17. Histidine based pH-responsive polymeric micelle for tumor: Original research article: Polymeric micelle for tumor pH folate-mediated targeting, 2003

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

17. Histidine based pH-responsive polymeric micelle for tumor: Original research article: Polymeric micelle for tumor pH folate-mediated targeting, 2003 - PubMed

15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003) - PubMed

15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003) - PubMed

15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003)

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003) - PubMed

13. From tissue engineering to therapeutic cancer vaccines: Original research article: Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, 2000 - PubMed

13. From tissue engineering to therapeutic cancer vaccines: Original research article: Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, 2000 - PubMed

13. From tissue engineering to therapeutic cancer vaccines: Original research article: Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, 2000

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

13. From tissue engineering to therapeutic cancer vaccines: Original research article: Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, 2000 - PubMed

12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) - PubMed

12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) - PubMed

12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998)

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) - PubMed

11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: a rugged path to the bright future: Original research article: Biodegradable electrospun fibers for drug delivery, 2003 - PubMed

11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: a rugged path to the bright future: Original research article: Biodegradable electrospun fibers for drug delivery, 2003 - PubMed

11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: a rugged path to the bright future: Original research article: Biodegradable electrospun fibers for drug delivery, 2003

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: a rugged path to the bright future: Original research article: Biodegradable electrospun fibers for drug delivery, 2003 - PubMed

10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002 - PubMed

10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002 - PubMed

10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002 - PubMed

9. Diagnostic and therapeutic applications of biocompatible gold nanorods: Original research article: PEG-modified gold nanorods with a stealth character for in vivo applications, 2006 - PubMed

9. Diagnostic and therapeutic applications of biocompatible gold nanorods: Original research article: PEG-modified gold nanorods with a stealth character for in vivo applications, 2006 - PubMed

9. Diagnostic and therapeutic applications of biocompatible gold nanorods: Original research article: PEG-modified gold nanorods with a stealth character for in vivo applications, 2006

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

9. Diagnostic and therapeutic applications of biocompatible gold nanorods: Original research article: PEG-modified gold nanorods with a stealth character for in vivo applications, 2006 - PubMed

8. Chitosan and chitosan oligomers for nucleic acid delivery: Original research article: Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, 1998 - PubMed

8. Chitosan and chitosan oligomers for nucleic acid delivery: Original research article: Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, 1998 - PubMed

8. Chitosan and chitosan oligomers for nucleic acid delivery: Original research article: Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, 1998

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

8. Chitosan and chitosan oligomers for nucleic acid delivery: Original research article: Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, 1998 - PubMed

7. Ethosomes - an innovative carrier for enhanced delivery into and across the skin: Original research article: Ethosomes - novel vesicular carriers for enhanced delivery: characterization skin penetration properties, 2000 - PubMed

7. Ethosomes - an innovative carrier for enhanced delivery into and across the skin: Original research article: Ethosomes - novel vesicular carriers for enhanced delivery: characterization skin penetration properties, 2000 - PubMed

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

7. Ethosomes - an innovative carrier for enhanced delivery into and across the skin: Original research article: Ethosomes - novel vesicular carriers for enhanced delivery: characterization skin penetration properties, 2000 - PubMed

6. Reflections on the emergence of new thematic research: development of electrospun nanostructured DNA delivery scaffolds: Original research article: Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA PLA-PEG block copolymers, 2003 - PubMed

6. Reflections on the emergence of new thematic research: development of electrospun nanostructured DNA delivery scaffolds: Original research article: Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA PLA-PEG block copolymers, 2003 - PubMed

6. Reflections on the emergence of new thematic research: development of electrospun nanostructured DNA delivery scaffolds: Original research article: Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA PLA-PEG block copolymers, 2003

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

6. Reflections on the emergence of new thematic research: development of electrospun nanostructured DNA delivery scaffolds: Original research article: Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA PLA-PEG block copolymers, 2003 - PubMed

4. Poly(NIPAAm) revisited - it has been 28 years since it was first proposed for use as a biomaterial: Original research article: Applications of thermally reversible polymers hydrogels in therapeutics and diagnostics, 1987; thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions, 1986; a novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery, 1991 - PubMed

4. Poly(NIPAAm) revisited - it has been 28 years since it was first proposed for use as a biomaterial: Original research article: Applications of thermally reversible polymers hydrogels in therapeutics and diagnostics, 1987; thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions, 1986; a novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery, 1991 - PubMed

4. Poly(NIPAAm) revisited - it has been 28 years since it was first proposed for use as a biomaterial: Original research article: Applications of thermally reversible polymers hydrogels in therapeutics and diagnostics, 1987; thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions, 1986; a novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery, 1991

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

4. Poly(NIPAAm) revisited - it has been 28 years since it was first proposed for use as a biomaterial: Original research article: Applications of thermally reversible polymers hydrogels in therapeutics and diagnostics, 1987; thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions, 1986; a novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery, 1991 - PubMed

5. A short commentary on stimuli-responsive hydrogels for drug delivery: Original research article: Thermally on-off switching polymers for drug permeation release, 1990 - PubMed

5. A short commentary on stimuli-responsive hydrogels for drug delivery: Original research article: Thermally on-off switching polymers for drug permeation release, 1990 - PubMed

5. A short commentary on stimuli-responsive hydrogels for drug delivery: Original research article: Thermally on-off switching polymers for drug permeation release, 1990

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

5. A short commentary on stimuli-responsive hydrogels for drug delivery: Original research article: Thermally on-off switching polymers for drug permeation release, 1990 - PubMed

1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987 - PubMed

1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987 - PubMed

1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987 - PubMed

3. Electrospun polymer fibers as a versatile delivery platform for small molecules and macromolecules: Original research article: Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), a blend, 2002 - PubMed

3. Electrospun polymer fibers as a versatile delivery platform for small molecules and macromolecules: Original research article: Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), a blend, 2002 - PubMed

3. Electrospun polymer fibers as a versatile delivery platform for small molecules and macromolecules: Original research article: Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), a blend, 2002

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

3. Electrospun polymer fibers as a versatile delivery platform for small molecules and macromolecules: Original research article: Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), a blend, 2002 - PubMed

The ancient vocabulary of medical prescriptions - PubMed

The ancient vocabulary of medical prescriptions - PubMed

The ancient vocabulary of medical prescriptions

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

The ancient vocabulary of medical prescriptions - PubMed

8th Pieter van Keep Memorial Lecture. Estrogen and bone: have we completed a full circle? - PubMed

8th Pieter van Keep Memorial Lecture. Estrogen and bone: have we completed a full circle? - PubMed

Estrogen therapy was considered first-line therapy for the prevention and treatment of postmenopausal osteoporosis in 1984. Evidence from a large, randomized clinical trial in 2002 proved the efficacy of estrogen in the prevention of all types of osteoporosis-related fractures. Ironically, estrogen …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

8th Pieter van Keep Memorial Lecture. Estrogen and bone: have we completed a full circle? - PubMed

Preoperative antibiotic colon preparation: have we had the answer all along? - PubMed

Preoperative antibiotic colon preparation: have we had the answer all along? - PubMed

Preoperative antibiotic colon preparation: have we had the answer all along?

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Preoperative antibiotic colon preparation: have we had the answer all along? - PubMed

Oral rehydration therapy in cholera - PubMed

Oral rehydration therapy in cholera - PubMed

Oral rehydration therapy in cholera

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Oral rehydration therapy in cholera - PubMed

Clinical research before informed consent - PubMed

Clinical research before informed consent - PubMed

Clinical research with patient-subjects was routinely conducted without informed consent for research participation prior to 1966. The aim of this article is to illuminate the moral climate of clinical research at this time, with particular attention to placebo-controlled trials in which patient-sub …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Clinical research before informed consent - PubMed

In honour of Professor Kazunori Kataoka, recipient of the Journal of Drug Targeting's Life-time Achievement Award for 2014 - PubMed

In honour of Professor Kazunori Kataoka, recipient of the Journal of Drug Targeting's Life-time Achievement Award for 2014 - PubMed

In honour of Professor Kazunori Kataoka, recipient of the Journal of Drug Targeting's Life-time Achievement Award for 2014

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

In honour of Professor Kazunori Kataoka, recipient of the Journal of Drug Targeting's Life-time Achievement Award for 2014 - PubMed

Opioid dependence, a life-threatening condition, is preventable - PubMed

Opioid dependence, a life-threatening condition, is preventable - PubMed

Opioid dependence, a life-threatening condition, is preventable

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Opioid dependence, a life-threatening condition, is preventable - PubMed

Opioid substitution treatment in New Zealand: a 40 year perspective - PubMed

Opioid substitution treatment in New Zealand: a 40 year perspective - PubMed

We provide an overview of the history and philosophy of the treatment for opioid dependence, which has been dominated by methadone substitution treatment for the past 40 years in New Zealand. Although changes in approach have occurred over this time, influenced by various sociopolitical events and c …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Opioid substitution treatment in New Zealand: a 40 year perspective - PubMed

An integrated approach to individualized optimal dose estimation of medication by means of dosing adjustment measures and Bi-Digital O-Ring Test - PubMed

An integrated approach to individualized optimal dose estimation of medication by means of dosing adjustment measures and Bi-Digital O-Ring Test - PubMed

Posology concerns science and system of dosage. Conventionally the dosage systems of measurement are the apothecaries' and metric systems and the dosage calculation for each individual patient has been suggested according to several available methods, namely Clark's Rule, Fried's Rule, Young's Rule, …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

An integrated approach to individualized optimal dose estimation of medication by means of dosing adjustment measures and Bi-Digital O-Ring Test - PubMed

"Take your pill": the role and fantasy of pills in modern medicine - PubMed

"Take your pill": the role and fantasy of pills in modern medicine - PubMed

The pharmaceutical industry has undergone a vast expansion in the 20th and 21st centuries. This article explores the central role now played by pills in clinical practice, but also in the public imagination. First, this article analyzes four properties that, together, account for many of the promise …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

"Take your pill": the role and fantasy of pills in modern medicine - PubMed

Controlled drug delivery systems: past forward and future back - PubMed

Controlled drug delivery systems: past forward and future back - PubMed

Controlled drug delivery technology has progressed over the last six decades. This progression began in 1952 with the introduction of the first sustained release formulation. The 1st generation of drug delivery (1950-1980) focused on developing oral and transdermal sustained release systems and esta …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Controlled drug delivery systems: past forward and future back - PubMed

Advocating for opioid substitution therapy in Central Asia: much still to be done - PubMed

Advocating for opioid substitution therapy in Central Asia: much still to be done - PubMed

Opioid substitution therapy (OST) was first introduced in the formerly-Soviet Central Asian Republics as an HIV prevention intervention for people who inject drugs (PWID) in 2002. Presently, pilot programs function in Kazakhstan and Tajikistan, and Kyrgyzstan has scaled-up from the pilot phase to th …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Advocating for opioid substitution therapy in Central Asia: much still to be done - PubMed

Hydrogels in a historical perspective: from simple networks to smart materials - PubMed

Hydrogels in a historical perspective: from simple networks to smart materials - PubMed

Over the past decades, significant progress has been made in the field of hydrogels as functional biomaterials. Biomedical application of hydrogels was initially hindered by the toxicity of crosslinking agents and limitations of hydrogel formation under physiological conditions. Emerging knowledge i …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Hydrogels in a historical perspective: from simple networks to smart materials - PubMed